Accurate results
for patient care
Laboratory medicine and in vitro diagnostics

JCTLM Database: higher-order reference materials, methods and services

Details : C20RM1 - Anti-β 2 GPI IgG in human serum

Type (acronym)rm2
Typereference material
Unique Nomination NumberC20RM1
Analyte NameAnti-beta 2 glycoprotein I IgG antibodies
List I, II or IIIList II
Basis for Traceability ClaimTraceable to the assigned value of WHO international standard NIBSC 21/266 via direct value transfer
Applicable Matriceshuman serum
Identifier NumberERM®- DA477/IFCC
Name
Anti-β 2 GPI IgG in human serum
Certifying OrganizationJRC expiration date :1 year after sales date, stability of CRM continuously monitored over the whole lifetime
QuantityConcentration of International Units
From (0)200
To (0)200
Unit (0)IU/mL
From (1)189
To (1)211
Unit (1)IU/mL
Level of Confidence (%)95%
Reference to Commutability Study PublicationReport on the collaborative study to establish the 1st WHO International Standard for anti β2GPI Immunoglobulin G in human serum, Monogioudi E. et al, Publication WHO/BS/2022.2420
Other Relevant PublicationsEuropean Commission, Joint Research Centre, Monogioudi, E., Martos, G., Trapmann, S. et al., The certification of the concentration of anti-β2-glycoprotein I IgG in human serum – ERM®-DA477/IFCC – Certification report, Publications Office of the European Union, 2022, DOI:10.2760/943468
Organization AcronymEU - JRC
Organization NameEuropean Commission - Joint Research Centre
Organization Websitehttps://crm.jrc.ec.europa.eu/
Organization Country ISO CodeBE
Organization Country NameBelgium
Analyte Category NameProteins